NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $150,000 | -98.1% | 12,376 | -94.5% | 0.00% | -98.0% |
| Q4 2021 | $7,735,000 | -32.4% | 226,704 | -4.5% | 0.20% | -35.2% |
| Q3 2021 | $11,448,000 | +7.1% | 237,323 | +0.3% | 0.31% | +2.7% |
| Q2 2021 | $10,687,000 | -5.7% | 236,591 | +0.7% | 0.30% | -12.6% |
| Q1 2021 | $11,328,000 | -23.0% | 234,868 | -14.0% | 0.34% | -22.3% |
| Q4 2020 | $14,704,000 | +45.0% | 273,100 | -0.6% | 0.44% | +18.0% |
| Q3 2020 | $10,139,000 | +21.6% | 274,835 | +2.1% | 0.37% | +21.5% |
| Q2 2020 | $8,340,000 | +670.1% | 269,205 | +586.1% | 0.31% | +479.2% |
| Q1 2020 | $1,083,000 | -23.8% | 39,239 | -19.2% | 0.05% | -11.7% |
| Q4 2019 | $1,421,000 | +53.0% | 48,570 | 0.0% | 0.06% | +46.3% |
| Q3 2019 | $929,000 | -12.9% | 48,570 | -0.0% | 0.04% | -10.9% |
| Q2 2019 | $1,066,000 | +3.5% | 48,590 | -3.4% | 0.05% | -4.2% |
| Q1 2019 | $1,030,000 | +108.1% | 50,325 | +28.2% | 0.05% | +84.6% |
| Q4 2018 | $495,000 | – | 39,250 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 396,327 | $8,109,000 | 6.56% |
| Cowen Prime Services LLC | 584,766 | $11,964,000 | 6.20% |
| 1492 Capital Management LLC | 269,488 | $5,514,000 | 4.67% |
| First Light Asset Management, LLC | 1,604,611 | $32,830,000 | 4.27% |
| PERKINS CAPITAL MANAGEMENT INC | 264,650 | $5,415,000 | 3.56% |
| FALCON POINT CAPITAL, LLC | 219,992 | $4,501,000 | 2.45% |
| Granite Investment Partners, LLC | 1,764,090 | $36,093,000 | 2.05% |
| Ranger Investment Management | 1,209,535 | $24,747,000 | 1.79% |
| EMERALD ADVISERS, LLC | 1,878,901 | $38,442,000 | 1.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,875,759 | $38,378,000 | 1.54% |